Average Co-Inventor Count = 8.67
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (31 from 4,942 patents)
2. Novartis Ag (1 from 3,923 patents)
3. Siena Biotech S.p.a. (1 from 11 patents)
4. F. Hoffmann-la Roche Ag (168 patents)
32 patents:
1. 12281124 - Heterocyclic compounds as monoacylglycerol lipase inhibitors
2. 11814375 - Heterocyclic compounds
3. 11802133 - Heterocyclic compounds as monoacylglycerol lipase inhibitors
4. 11608347 - Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors
5. 11420961 - Heterocyclic compounds
6. 11390610 - Piperazine derivatives as MAGL inhibitors
7. 11059858 - Difluoroketamide derivatives as HtrA1 inhibitors
8. 11014963 - Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
9. 11001555 - Difluoroketamide derivatives as HTRA1 inhibitors
10. 10870623 - Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
11. 10865182 - Difluoroketamide derivatives as HtrA1 inhibitors
12. 10428108 - Difluoroketamide derivatives
13. 10035804 - Spirodiamine derivatives as aldosterone synthase inhibitors
14. 9980929 - Trifluoromethylpropanamide derivatives
15. 9796702 - Dihydroquinoline pyrazolyl compounds